Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study.

Kunisaki C, Ono HA, Hasegawa S, Oshima T, Fujii S, Tokuhisa M, Izumisawa Y, Takagawa R, Kimura J, Kosaka T, Makino H, Akiyama H, Endo I.

J Chemother. 2012 Dec;24(6):364-8. doi: 10.1179/1973947812Y.0000000042.

PMID:
23174102
2.

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer.

Kang BW, Kim JG, Chae YS, Lee YJ, Lee SJ, Moon JH, Sohn SK, Jung MK, Jeon SW, Jang YJ, Seo J, Lee YH, Kwon O, Chung HY, Yu W.

Invest New Drugs. 2012 Aug;30(4):1671-5. doi: 10.1007/s10637-011-9729-y.

PMID:
21845514
3.

Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.

Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J, Ohta T.

Anticancer Drugs. 2009 Sep;20(8):752-6. doi: 10.1097/CAD.0b013e32832ec02b.

PMID:
19543076
4.

[Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].

Hamakawa T, Kurokawa Y, Takiguchi S, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Mori M, Dok Y.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2342-4. Japanese.

PMID:
22202376
5.

Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer.

Quintero-Aldana G, Jorge M, Grande C, Salgado M, Gallardo E, Varela S, López C, Villanueva MJ, Fernández A, Alvarez E, González P, Castellanos J, Casal J, López R, Campos Balea B.

Cancer Chemother Pharmacol. 2015 Oct;76(4):731-7. doi: 10.1007/s00280-015-2839-z.

PMID:
26242221
6.

[A case of advanced gastric cancer showing pathological CR after neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 combination].

Usuda A, Nashimoto A, Yabusaki H, Nakagawa S, Matsuki A, Tsuchiya Y, Takii Y, Nomura T, Maruyama S, Homma K.

Gan To Kagaku Ryoho. 2011 Oct;38(10):1687-90. Japanese.

PMID:
21996968
7.

[Efficacy and safety of S-1 plus docetaxel combination therapy for patients with advanced gastric cancer].

Nishiwaki H, Yamada T, Tachi K, Iwasaki H, Hori Y, Umemura S, Yamakawa Y, Kurimoto T, Ban T, Fujiwara K, Hayashi K, Nemoto A, Shiroko J, Orito E.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1663-6. Japanese.

PMID:
19838024
8.

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

Sato Y, Takayama T, Sagawa T, Takahashi Y, Ohnuma H, Okubo S, Shintani N, Tanaka S, Kida M, Sato Y, Ohta H, Miyanishi K, Sato T, Takimoto R, Kobune M, Yamaguchi K, Hirata K, Niitsu Y, Kato J.

Cancer Chemother Pharmacol. 2010 Sep;66(4):721-8. doi: 10.1007/s00280-009-1215-2.

PMID:
20041328
9.

A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601).

Nakayama N, Koizumi W, Sasaki T, Higuchi K, Tanabe S, Nishimura K, Katada C, Nakatani K, Takagi S, Saigenji K.

Oncology. 2008;75(1-2):1-7. doi: 10.1159/000151613.

PMID:
18719348
10.

A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Kimura Y, Yano H, Imamura H, Fujitani K, Imano M, Tokunaga Y, Matsuoka M, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H.

Jpn J Clin Oncol. 2013 Feb;43(2):125-31. doi: 10.1093/jjco/hys204.

PMID:
23225911
11.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5.

PMID:
23338051
12.

Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.

Kim YH, Seo HY, Jeen YT, Kim HK, Shim BY, Yang J.

Cancer Chemother Pharmacol. 2009 Jan;63(2):253-60. doi: 10.1007/s00280-008-0734-6.

PMID:
18493761
13.

Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Hironaka S, Yamazaki K, Taku K, Yokota T, Shitara K, Kojima T, Ueda S, Machida N, Muro K, Boku N.

Jpn J Clin Oncol. 2010 Nov;40(11):1014-20. doi: 10.1093/jjco/hyq104.

PMID:
20603245
14.

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601).

Koizumi W, Nakayama N, Tanabe S, Sasaki T, Higuchi K, Nishimura K, Takagi S, Azuma M, Ae T, Ishido K, Nakatani K, Naruke A, Katada C.

Cancer Chemother Pharmacol. 2012 Feb;69(2):407-13. doi: 10.1007/s00280-011-1701-1.

PMID:
21796483
15.

Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer.

Wang B, Zhang W, Hong X, Guo Y, Li J.

Cancer Chemother Pharmacol. 2009 Jan;63(2):213-8. doi: 10.1007/s00280-008-0728-4.

PMID:
18343924
16.

[Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].

Hori T, Ikehara T, Takatsuka S, Fukuoka T, Tendo M, Tezuka K, Dan N, Nishino H, Hirakawa K.

Gan To Kagaku Ryoho. 2011 Feb;38(2):293-5. Japanese.

PMID:
21368498
17.

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.

Zang DY, Yang DH, Kim MJ, Jang KM, Hwang SW, Yoo KS, Han T, Kim HY, Kim HJ, Kwon JH, Song HH, Park S, Jung JY, Kim HS, Kim JH.

Cancer Chemother Pharmacol. 2009 Oct;64(5):877-83. doi: 10.1007/s00280-009-0936-6.

PMID:
19190908
18.

[Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].

Fujiwara Y, Takiguchi S, Nakajima K, Miyata H, Yamazaki M, Nishida T, Doki Y.

Gan To Kagaku Ryoho. 2008 Nov;35(12):1996-8. Japanese.

PMID:
19106502
19.

Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.

Migita K, Nashimoto A, Yabusaki H, Matsuki A, Aizawa M.

Int J Clin Oncol. 2016 Feb;21(1):102-9. doi: 10.1007/s10147-015-0851-2.

PMID:
26017926
20.

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.

Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS.

Cancer Chemother Pharmacol. 2008 Apr;61(5):837-45.

PMID:
17579864

Supplemental Content

Support Center